Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-14
2006-02-14
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C424S538000, C424S094620, C424S094600
Reexamination Certificate
active
06998389
ABSTRACT:
The present invention describes pharmaceutically effective substances from the poison of spiders of the family of Sicariidae as well as their preparation and their use in medicine.
REFERENCES:
patent: 4877741 (1989-10-01), Babcock et al.
patent: 4925664 (1990-05-01), Jackson et al.
patent: 5196193 (1993-03-01), Carroll
patent: WO 95/19989 (1995-07-01), None
Bettini, Sergio (ed.),Arthropod Venoms, pp. 251-260.Handbuch der experimentellen Pharmakologie(Handbook of Experimental Pharmacology), vol. 48 (1978).
Burda, R. et al. “Zellzerstörende Giftkomponenten von Spinnen der Gattung Sicarius bei der Therapie von Tumorkrankungen (Cell Destructive Toxic Components of Spiders of the Genus Sicarius for Tumor Therapy).”Årztezeitschrift für Naturheilverfahren41, 3, pp. 172-177 (2000).
Geren, Collis R. et al. “Isolation and Characterization of Toxins from Brown Recluse Spider Venom (Loxosceles reclusa).”Archives of Biochemistry and Biophysics174, pp. 90-99 (1976).
Kurpiewski, Gretchen et al. “Platelet Aggregation and Sphingomyellnase D Activity of a Purified Toxin from the Venom of Loxosceles Reclusa.”Toxicology, vol. 96, pp. 166-167 (1982).
Merchant, Michael et al. “Observation of Phospholipase Activity in the Venom of the Brown Recluse Spider (Loxosceles Reclusa) by Phosphorous-31 NMR.”FASEB Journal, vol. 9, No. 6, p. A1313. Meeting Info: Annual Meeting of the American Society for Biochemistry and Molecular Biology, San Francisco, California, May 21-25, 1995.
Suárez, Gerardo et al. “Effect Extracts of the Venom Gland of the Recluse Spider,Loxosceles Laela, on Human Cells in Culture.”Toxicon, vol. 14, pp. 335-337 (1976).
Wright, R.P. et al. “Hyaluronidase and Esterase Activities of the Venom of the Poisonous Brown Recluse Spider.”Archives of Biochemistry and Biophysics159, pp. 415-426 (1973).
Heines M. Henry
Townsend and Townsend / and Crew LLP
Toximed GmbH
Witz Jean C.
LandOfFree
Pharmaceutical composition comprised of spider venoms, the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprised of spider venoms, the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprised of spider venoms, the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701209